Most studies do not consider the possible immunoregulatory impact of the soluble form of CTLA-4 even though it is evident that blocking CTLA-4 can trigger anti-tumor immunity by promoting the infiltration of cytotoxic effector T cells into tumors.34 The gene discussed is CTLA4; the disease is neoplasm.